Zoetis has announced an expansion of Vetscan OptiCell that it says will make it the first point-of-care haematology analyser to offer cellular haemoglobin concentration mean (CHCM), giving practices access to a parameter that was previously available only…

Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle¹.

In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with…

Zoetis, the maker of UlcerGold, has announced the launch of a digital tool to support veterinary surgeons with the diagnosis of Equine Gastric Ulceration Syndrome (EGUS).

The new tool is part of a package that also includes posters and SMS texts to…

Zoetis has launched Stablelab, a hand-held, point-of-care blood test that gives veterinary surgeons diagnostic information about equine inflammation in 10 minutes.

The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA…

Zoetis has added digital cytology testing to Vetscan Imagyst, giving practices access to a network of remote pathologists and AI technology for fecal testing. 

With Vetscan Imagyst, samples are prepared in-clinic using traditional methods, but submitted digitally…

Zoetis UK has added AI urine sediment analysis to its diagnostics platform, Vetscan Imagyst.

The company says the new addition leverages a combination of image recognition technology, algorithms, and cloud-based deep learning AI to enable accurate, in…

Zoetis is going to preview its new cartridge-based point-of-care haematology analyser, Vetscan OptiCell, at the London Vet Show (Stand N50, London Excel, 14th/15th November).

Zoetis says the Vetscan OptiCell represents a significant leap forward in technology…

Zoetis has announced that Vetscan Imagyst, its multi-purpose diagnostic tool, is getting 'AI Masses', a new capability which uses AI to analyse potentially neoplastic cells in lymph node and subcutaneous lesions.

The company says AI Masses wil…

Zoetis is launching AI Masses, a new cytological capability for Vetscan Imagyst which detects potentially neoplastic cells, at the London Vet Show 2025 (Excel London, 20-21 November, stand N50).

Zoetis says AI Masses delivers fast, accurate, in-clinic screening…

Zoetis has strengthened its diagnostics portfolio with the acquisition of Veterinary Pathology Group (VPG), a veterinary diagnostic laboratory group with multiple locations across the UK and Ireland.

Mike Ellinger, Business Unit Director, UK Diagnostics…